CONI 2.6
Glyceryl Trinitrate 2.6mg Controlled Release Tablets
Coni-2.6, a high-quality pharmaceutical formulation by Novalab Cardiac & Diabetic Care. If you are looking for reliable information regarding Glyceryl Trinitrate 2.6mg Controlled Release Tablets, you have come to the right place. Our mission is to provide premium cardiac care solutions that support a healthy and active lifestyle.
Coni-2.6 is a specialized medication containing Glyceryl Trinitrate (GTN) in a 2.6mg strength. These are “Controlled Release” (CR) tablets, which means the active ingredient is released slowly and steadily into the bloodstream over an extended period. This advanced delivery system ensures that the body maintains a consistent level of the medication, providing long-lasting support throughout the day.
Glyceryl Trinitrate belongs to a class of medicines known as nitrates. It is widely recognized in the medical community for its efficiency in managing heart-related conditions, particularly those involving the blood vessels.
The primary active ingredient in Coni-2.6 is:
The “Controlled Release” technology used in Coni-2.6 is what sets it apart. Unlike immediate-release tablets, the 2.6mg dose in Coni-2.6 is formulated to work gradually. This makes it an ideal choice for managing chronic conditions and promoting long-term wellness.
Coni-2.6 is primarily used for the prevention and long-term management of chest pain, also known as Angina Pectoris. Here are the primary uses:
Choosing Coni-2.6 offers several benefits for individuals focusing on cardiac health:
The primary function of Glyceryl Trinitrate is to dilate (widen) the blood vessels. By doing so, it allows oxygen-rich blood to reach the heart muscle more easily, which is essential for maintaining cardiac stamina.
When blood vessels are relaxed, the heart does not have to pump as hard to circulate blood throughout the body. This reduction in “preload” and “afterload” is a significant benefit for long-term heart maintenance.
Because Coni-2.6 is a controlled-release tablet, it provides a steady effect. Users benefit from a consistent therapeutic level of medication, which helps in avoiding the “peaks and valleys” often associated with standard tablets.
By effectively managing the symptoms of chronic angina, Coni-2.6 allows individuals to engage in daily activities with more confidence and less discomfort.
At Novalab Cardiac & Diabetic Care, we prioritize quality and precision. Our Coni-2.6 tablets are manufactured under strict quality control standards to ensure that every dose is effective.
The science behind Coni-2.6 is fascinating. Once consumed, the Glyceryl Trinitrate is converted into nitric oxide in the body. Nitric oxide is a natural signaling molecule that tells the muscles in the blood vessel walls to relax. This relaxation leads to vasodilation, which immediately improves the delivery of oxygen to the heart. This process is vital for anyone managing chronic stable angina.
| Feature | Details |
| Product Name | Coni-2.6 |
| Composition | Glyceryl Trinitrate 2.6mg |
| Form | Controlled Release Tablets |
| Category | Cardiac Care / Nitrates |
| Pack Size | 30 Tablets |
| MRP | ₹175.00 |
For more information or to inquire about bulk orders, visit our website at www.novalabcardiac.com or contact us via email at novalab7777@gmail.com.
This will close in 0 seconds
Automated page speed optimizations for fast site performance